Delivery Order 75N94020D00016-75N94021F00001
Award Date 2/9/21
Potential Completion Date 2/8/26
Potential Value $445K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Portland, OR 97239, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Child Health and Human Development (NICHD) awarded a delivery order contract to Oregon Health & Science University (OHSU) on August 1, 2025, with a ceiling value of $641,267.76 and a completion date of December 31, 2028. The contract is a cost-no-fee arrangement with no set-aside designation. Under this non-severable delivery order, OHSU will conduct research and development activities to evaluate the pharmacokinetics, pharmacodynamic effects, safety, and...
- This is a federal contract award from the National Institute of Child Health and Human Development, a civilian agency within the U.S. Department of Health and Human Services, to Oregon Health & Science University (OHSU). The contract is for the pharmacokinetic/pharmacodynamic evaluation of levonorgestrel butanoate for female contraception, with a ceiling value of $622,909.06 and a period of performance through July 14, 2026. The contract is a delivery order and is not set aside for any...
- This is a delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU) for the clinical evaluation of novel female contraception products. The contract has a period of performance from November 9, 2015 to November 8, 2018, with an ultimate completion date of September 30, 2022. The contract is a firm fixed price award with a ceiling value of $160,379.14. It does not have a set-aside...
- This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU) for the "Clinical Evaluation of Long-Acting Reversible Contraceptives (LARC)." The contract has a period of performance from September 25, 2015, to September 24, 2018, with an ultimate completion date of March 1, 2024, and a ceiling value of $682,341.24. The contract is a delivery order and is priced on a...
- This federal contract award, with ID 75N94020D00016|75N94020F00001, was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU) to provide services related to the NICHD Contraceptive Clinical Trials Network (CCTN) - Female Sites: Core Function Activities program. The contract is a delivery order with a cost-no-fee pricing type and a ceiling value of $69,992.65. The contract is not set aside for any...
- This federal contract award, valued at $1,235,833.08, was issued by the National Institute of Child Health and Human Development (NICHD) to Oregon Health & Science University (OHSU) to conduct a multi-center, randomized study evaluating the pharmacokinetic and pharmacodynamic profile, contraceptive efficacy, and safety of daily oral low dose ulipristal acetate. The contract is not set aside for any specific business type. OHSU has subcontracted portions of the work to the University of...
- This is a federal contract award from the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU), a U.S. state government, educational institution, and state-controlled institution of higher learning. The $133,612.31 contract is for the provision of assistance in protocol review, protocol development, and activities associated with the past, present, and future of the Contraceptive Clinical Trials Network (CCTN)...
- This federal contract award was made by the National Institute of Child Health and Human Development, a civilian agency, to Oregon Health & Science University (OHSU) for a Contraceptive Clinical Trial. The contract has a ceiling value of $653,663.79 and is a Delivery Order with a Cost No Fee pricing type. The contract does not have a set-aside designation. OHSU is a major research university and academic medical center that frequently receives federal funding through contracts and grants,...
- This federal contract award is a delivery order issued under the "THE STATISTICAL AND CLINICAL COORDINATING CENTER IDIQ" contract, which was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency. The contract is for R&D support for a Phase IIb clinical trial of subcutaneous levonorgestrel butanoate (LB) for female contraception. The contract is non-severable and has a ceiling value of $2,355,840.00. The prime contractor is Health...
- This is a federal contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU) for an open-label trial on the efficacy, cycle control, and safety of a contraceptive vaginal ring delivering a daily dose of Nestorone and ethinyl estradiol. The contract has a ceiling value of $1,406,546.35 and does not have a set-aside designation. OHSU is a prominent research university and academic medical center that...
- 75N94020D00016Indefinite Delivery Contract
- 75N94020D00016-75N94021F00001Delivery Order
The National Institute of Child Health and Human Development (NICHD) awarded a $444,793.00 cost-no-fee delivery order contract to Oregon Health & Science University (OHSU) to provide a central laboratory for pharmacokinetic and pharmacodynamic evaluation of levonorgestrel butanoate for female contraception. This contract is part of NICHD's Contraceptive Development Program and Contraceptive Clinical Trials Network. The contract has a period of performance through February 8, 2026 and does not have a set-aside designation.
Generated 8/23/24, 4:38 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Funding Only Action | $95.1k | 8/22/24 | |
| P00002 | Funding Only Action | $199.1k | 12/21/22 | |
| P00001 | Funding Only Action | $30.1k | 9/13/22 | |
| Not listed | Not listed | $120.6k | 2/9/21 |